| Financial Year |
March 31 2022 |
| Monetary Funds |
845,706,524.29 |
| Held-for-trading Financial Assets |
518,775,083.34 |
| Notes Receivable |
253,074,954.56 |
| Accounts Receivable |
1,234,478,085.78 |
| Advances to Suppliers |
255,594,096.90 |
| Other Receivables |
142,947,133.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,618,369,122.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
105,033,365.60 |
| Total Current Assets |
5,235,527,167.33 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
285,788,149.55 |
| Investment Properties |
239,656,860.46 |
| Fixed Assetes |
346,338,666.80 |
| Under-construction Projects |
3,657,135.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
116,057,176.65 |
| R&D expenses |
-- |
| Goodwill |
108,528,729.06 |
| Long-Term Deferred and Prepaid Expenses |
9,883,083.31 |
| Deferred Income Tax Assets |
65,163,098.93 |
| Other Non-Current Assets |
19,745,269.74 |
| Sub-Total of Non-Current Assets |
1,230,333,001.08 |
| Total Assets |
6,465,860,168.41 |
| Short-Term Loans |
453,215,395.58 |
| Trading Financial liabilities |
-- |
| Notes Payable |
925,655,175.64 |
| Accounts Payable |
1,230,093,180.73 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
34,068,038.04 |
| Taxes Payable |
41,399,077.39 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
93,540,005.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,236,395.73 |
| Other Current Liabilities |
126,175,888.38 |
| Sub-Total of Current Liabilities |
3,810,124,626.56 |
| Long-term Loans |
185,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
24,185,534.31 |
| Deferred Income Tax Liabilities |
736,826.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
468,927,117.04 |
| Total Liabilities |
4,279,051,743.60 |
| Paid-In Capital(Or Share Stock) |
780,242,234.00 |
| Capital Surplus |
3,289,915,231.62 |
| Surplus Reserve |
33,244,430.45 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,047,529,276.86 |
| Minority Stockholder's Interest |
132,486,339.75 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,054,322,085.06 |
| Owner's Equity（Stockholder's Equity） |
2,186,808,424.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,465,860,168.41 |
